Actionable insights straight to your inbox

Equities logo

Radient Technologies Inc. (RTI) Announces Master Services Agreement with Medical Cannabis Supplier Bonify

Radient Technologies Inc. (TSX-V:RTI) announces the signing of a Master Services Agreement to produce a variety of cannabis extracts for Bonify.

Radient Technologies Inc. (TSX-V:RTI) announces the signing of a Master Services Agreement to produce a variety of cannabis extracts for Bonify, a private, Manitoba-based Canadian-Licensed producer of medical cannabis.

Under the terms of this Agreement, Radient will use its proprietary microwave-based extraction platform and decades of extraction expertise to deliver “Extraction as a Service” to Bonify, an innovative, quality-driven Authorized Licensed Producer of Cannabis for Medical Purposes. From its Edmonton extraction facility, Radient will process Bonify’s cultivated cannabis material to deliver standardized cannabis oil products. Both Bonify and Radient remain open to the exploration of possible synergies for future collaboration beyond this Master Services Agreement.

The terms of this Agreement were reached on the basis of Radient’s ability to provide solutions for Bonify’s key production demands, including:

Increased purity — Bonify’s product offerings are categorized into several varieties based on the ratio of bioactive content (tetrahydrocannabinol or “THC” and cannabidiol or “CBD”) they contain. Radient’s platform can consistently deliver extraction efficiencies of up to 98%, while nearly fully preserving cannabinoid terpene profiles, and enabling the standardization of the strength/dosage of active ingredients.

Cost efficiency — Radient’s MAP™ extraction technology has the proven ability to generally extract more active compounds from valuable cannabis biomass than conventional extraction methods, usually resulting in higher yields with greater purity, while also decreasing time, energy and solvent used during production.

Scalability — Bonify’s national and international market plans will require the processing of large quantities of cannabis into oils. Radient’s proprietary extraction technology has demonstrated throughputs of over 1,500 kg of biomass per day.

“We look forward to working with Bonify in delivering products that maintain the highest standards of quality assurance and consistency, at a scale that meets Bonify’s current and future growth plans,” commented Mike Cabigon, COO of Radient. “This Agreement is another key milestone for Radient as we establish a leadership position within the cannabis value chain.”

Mark Smolenski, COO of Bonify, stated, “Our team is excited to partner with Radient to utilize their proven, cost-effective extraction platform for the production of innovative, high value, cannabis-derived products. The market for these products is growing at a rapid rate across the globe. Through this Agreement, we will keep pace with this accelerating demand and strengthen our position as a leading provider of medical cannabis products.”

About Bonify:
Bonify is a Canadian-owned leading provider of medical cannabis, with over 1,000,000 square feet of potential productive capacity at its present site in Winnipeg, Manitoba, Canada. By maximizing research findings and strictly adhering to best in class practices, quality standards and procedures, Bonify produces cannabis-derived products to help individuals get the most out of life each and every day. Visit for more information.

About Radient:
Radient extracts natural compounds from a range of biological materials using microwave assisted processing (“MAP™”), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health and personal care markets. Since 2016, Radient has expanded its offerings to enter the cannabinoids market utilizing its MAP™ platform to process and extract cannabinoids including cannabidiol and tetrahydrocannabinol from cannabis biomass. Visit for more information.

In the interest of full disclosure, we call the reader’s attention to the fact that, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.